Pappas Ventures | MedCity News

Topic: Pappas Ventures

Orphan drug firm with potential first treatment for HIBM raises $15 million

August 14, 2012 12:01 pm by Deanna Pogorelc | 0 Comments

Ultragenyx is developing a sialic acid replacement therapy for treatment of the rare, progressive neuromuscular disease hereditary inclusion body myopathy that causes muscles to waste away. ... Read more

Plexxikon’s Glaub: personalized medicine is ‘the wave of the future’

October 7, 2011 6:09 pm by Frank Vinluan | 0 Comments

They came from all parts of North Carolina’s Research Triangle, and several of them from far beyond, to hear the story of how a small biotechnology company developed a breakthrough ... Read more

RTP venture capital climate improved in Q1 but biotechs still clamor for cash

April 13, 2011 12:18 am by Frank Vinluan | 0 Comments

Early stage life science companies still developing their technologies can fall into a gap: too expensive to be supported by more grants or angel investments yet not far enough along ... Read more

NC biotech CoLucid eyes phase 3 trials for novel migraine treatment

March 9, 2011 4:49 pm by Frank Vinluan | 0 Comments

A new migraine treatment from CoLucid Pharmaceuticals is approaching phase 3 clinical trials and the North Carolina-based company is raising $6.5 million in a bridge round of financing to get ... Read more

CeNeRx BioPharma raises $13M for trial of antidepression drug

August 13, 2010 10:52 am by Brandon Glenn | 0 Comments

CeNeRx BioPharma has raised a $13 million Series C round of financing that will fund phase 2 clinical trials of its antidepressant drug candidate. ... Read more

Gentis hopes to conquer spine market where others have failed

August 5, 2010 9:30 am by Brandon Glenn | 0 Comments

David Anderson says the road to developing an artificial spinal disc nucleus is littered with “spectacular failures.”But that doesn’t deter Anderson or his company, Philadelphia-based Gentis, from trying to be ... Read more